Cargando…

Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland

OBJECTIVE: New oral anticoagulants (NOACs) aim to overcome warfarin’s shortcomings, however their pharmacokinetic characteristics make prescribing complex. Thus it is imperative that general practitioners (GPs) are aware of specific treatments so as to maximise their benefits and minimise their pitf...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, A., Kirby, A., Bradley, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048694/
https://www.ncbi.nlm.nih.gov/pubmed/30012204
http://dx.doi.org/10.1186/s13104-018-3597-x
_version_ 1783340141440401408
author Murphy, A.
Kirby, A.
Bradley, C.
author_facet Murphy, A.
Kirby, A.
Bradley, C.
author_sort Murphy, A.
collection PubMed
description OBJECTIVE: New oral anticoagulants (NOACs) aim to overcome warfarin’s shortcomings, however their pharmacokinetic characteristics make prescribing complex. Thus it is imperative that general practitioners (GPs) are aware of specific treatments so as to maximise their benefits and minimise their pitfalls. This study explores GPs attitudes and experiences with prescribing NOACs in Ireland where, despite clear national prescribing guidelines advocating warfarin as first line therapy, the number of patients being prescribed NOACs for the first time is growing. RESULTS: Using primary data collected from GPs in Ireland the factors influencing the likelihood of a GP initiating a prescription for a NOAC are determined using a probit model. Results indicate 46% of the sample initiated NOAC prescriptions and GP practice size is a significant factor influencing this. Analysis revealed no difference regarding the sources of information considered important amongst GPs when prescribing new drugs. However, there were differences in which factors were considered important when prescribing anticoagulants between initiating and non-initiating NOAC prescribers. The results of this study suggest better utilisation of existing information and education tools for GPs prescribing NOACs and managing NOAC patients is imperative, to ensure the right anticoagulant is prescribed for the right patient at the right time.
format Online
Article
Text
id pubmed-6048694
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60486942018-07-19 Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland Murphy, A. Kirby, A. Bradley, C. BMC Res Notes Research Note OBJECTIVE: New oral anticoagulants (NOACs) aim to overcome warfarin’s shortcomings, however their pharmacokinetic characteristics make prescribing complex. Thus it is imperative that general practitioners (GPs) are aware of specific treatments so as to maximise their benefits and minimise their pitfalls. This study explores GPs attitudes and experiences with prescribing NOACs in Ireland where, despite clear national prescribing guidelines advocating warfarin as first line therapy, the number of patients being prescribed NOACs for the first time is growing. RESULTS: Using primary data collected from GPs in Ireland the factors influencing the likelihood of a GP initiating a prescription for a NOAC are determined using a probit model. Results indicate 46% of the sample initiated NOAC prescriptions and GP practice size is a significant factor influencing this. Analysis revealed no difference regarding the sources of information considered important amongst GPs when prescribing new drugs. However, there were differences in which factors were considered important when prescribing anticoagulants between initiating and non-initiating NOAC prescribers. The results of this study suggest better utilisation of existing information and education tools for GPs prescribing NOACs and managing NOAC patients is imperative, to ensure the right anticoagulant is prescribed for the right patient at the right time. BioMed Central 2018-07-16 /pmc/articles/PMC6048694/ /pubmed/30012204 http://dx.doi.org/10.1186/s13104-018-3597-x Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Note
Murphy, A.
Kirby, A.
Bradley, C.
Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland
title Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland
title_full Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland
title_fullStr Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland
title_full_unstemmed Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland
title_short Knowledge is power: general practitioners prescribing of new oral anticoagulants in Ireland
title_sort knowledge is power: general practitioners prescribing of new oral anticoagulants in ireland
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048694/
https://www.ncbi.nlm.nih.gov/pubmed/30012204
http://dx.doi.org/10.1186/s13104-018-3597-x
work_keys_str_mv AT murphya knowledgeispowergeneralpractitionersprescribingofneworalanticoagulantsinireland
AT kirbya knowledgeispowergeneralpractitionersprescribingofneworalanticoagulantsinireland
AT bradleyc knowledgeispowergeneralpractitionersprescribingofneworalanticoagulantsinireland